TAYLOR COPELAND: Open Payments
NPI 1730788944 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,811 in 155 payments from 21 companies in 2025. Trend: 2023 $2,908 · 2024 $3,772 · 2025 $3,811
Food & beverage: $3,746Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $645 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 24 | $577 |
| Novartis Pharmaceuticals Corporation | 16 | $380 |
| Galderma Laboratories, L.P. | 14 | $325 |
| ABBVIE INC. | 13 | $283 |
| LEO Pharma Inc. | 7 | $273 |
| Incyte Corporation | 5 | $200 |
| GENZYME CORPORATION | 9 | $166 |
| Regeneron Healthcare Solutions, Inc. | 5 | $142 |
| UCB, Inc. | 4 | $139 |
Products named: TREMFYA, ILUMYA, DUPIXENT, NEMLUVIO, COSENTYX, SKYRIZI, Opzelura, ADBRY.
Industry payments across TN — which companies pay providers there.
